ATAC-seq of human oesophageal adenocarcinoma OE19 cell line treated with lapatinib
Ontology highlight
ABSTRACT: To investigate changes to chromatin accessibility associated with resistance to lapatinib, we performed ATAC-seq on OE19 cells treated with 500 nM lapatinib for 1, 7 and 35 days and vehicle control (DMSO) for 1 day.
INSTRUMENT(S): Illumina HiSeq 4000
ORGANISM(S): Homo sapiens
SUBMITTER: Samuel Ogden
PROVIDER: E-MTAB-10302 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA